NCT06114511View on ClinicalTrials.gov

A Study of BL-M07D1 in Patients With HER2-mutated, Locally Advanced or Metastatic Non-small-cell Lung Cancer

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

April 24, 2024

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Non-small Cell Lung Cancer
Interventions
DRUG

BL-M07D1

Administration by intravenous infusion

Trial Locations (1)

Unknown

RECRUITING

Sun Yat-sen University Cancer Center, Guangzhou

All Listed Sponsors
lead

Sichuan Baili Pharmaceutical Co., Ltd.

INDUSTRY